Valence8 Us LP has filed its 13F form on November 12, 2024 for Q3 2024 where it was disclosed a total value porftolio of $241 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Msci Usa Quality Facto with a value of $60.5B, Invesco Qqq Trust, Series 1 with a value of $43B, Ishares Msci Intl Quality Fact with a value of $42.6B, Msci Eafe Value ETF with a value of $23B, and Vanguard Value ETF with a value of $16.9B.

Examining the 13F form we can see an increase of $49.2B in the current position value, from $192B to 241B.

Valence8 Us LP is based out at Cambridge, MA

Below you can find more details about Valence8 Us LP portfolio as well as his latest detailed transactions.

Portfolio value $241 Billion
ETFs: $219 Billion
Healthcare: $19 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $241 Billion
  • Prior Value $192 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 12, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 31 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Valence8 Us LP Portfolio

Follow Valence8 Us LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valence8 Us LP, based on Form 13F filings with the SEC.

News

Stay updated on Valence8 Us LP with notifications on news.